Va. Moore et al., INTERACTION OF OLIGONUCLEOTIDE-CONJUGATES WITH THE DIPEPTIDE TRANSPORTER SYSTEM IN CACO-2 CELLS, Biochemical pharmacology, 53(9), 1997, pp. 1223-1228
Oligonucleotide-based therapies represent novel strategies for manipul
ating the expression and function of target proteins and are undergoin
g clinical evaluation for the treatment of viral diseases and malignan
cies. However, poor biological stability and cellular delivery represe
nt potential limitations to the therapeutic development of oligonucleo
tides. Conjugation of oligonucleotides to lipophilic groups can improv
e delivery to cells but the enhanced cellular binding may also facilit
ate nonspecific interactions. In this report, we show that phosphoroth
ioate oligonucleotides conjugated to lipophilic groups, either tocophe
rol (Vitamin E) or 2-Di-O-hexadecyl-3-glycerol, can significantly inhi
bit the functioning of the dipeptide transporter system (DTS) in cultu
red Caco-2 intestinal cells. Because the DTS mediates the binding and
absorption of nutrient peptides and important drugs, such as the cepha
losporin and penicillin antibiotics, this finding has important implic
ations in relation to the potential toxicity of Lipophilic conjugates
in vivo. It also suggests a potential drug interaction with lipophilic
oligonucleotide-conjugates if they were to be delivered orally. (C) 1
997 Elsevier Science Inc.